Orchard Therapeutics PLC Price on December 2, 2024

ORTXDelisted Stock  USD 5.27  0.01  0.19%   
If you're considering investing in Orchard Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orchard Therapeutics stands at 5.27, as last reported on the 2nd of December, with the highest price reaching 5.40 and the lowest price hitting 5.25 during the day. We have found twenty-nine technical indicators for Orchard Therapeutics PLC, which you can use to evaluate the volatility of the company. Please check Orchard Therapeutics' Semi Deviation of 3.03, risk adjusted performance of 0.0378, and Coefficient Of Variation of 2577.42 to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Orchard Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ORTX
Based on monthly moving average Orchard Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orchard Therapeutics by adding Orchard Therapeutics to a well-diversified portfolio.

Orchard Therapeutics Valuation on December 2, 2024

It is possible to determine the worth of Orchard Therapeutics on a given historical date. On December 2, 2024 Orchard was worth 5.28 at the beginning of the trading date compared to the closed value of 5.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orchard Therapeutics stock. Still, in general, we apply an absolute valuation method to find Orchard Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orchard Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orchard Therapeutics' related companies.
 Open High Low Close Volume
12/02/2024
  5.28    5.40    5.25    5.27    0.00  
Backtest Orchard Therapeutics  |  Orchard Therapeutics History  |  Orchard Therapeutics Valuation 
Open Value
5.28
5.27
Closing Value
5.28
Upside

Orchard Therapeutics Trading Date Momentum on December 2, 2024

Orchard Therapeutics PLC Fundamentals Correlations and Trends

By evaluating Orchard Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orchard Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orchard financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Orchard Therapeutics Stock history

Orchard Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orchard is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orchard Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orchard Therapeutics stock prices may prove useful in developing a viable investing in Orchard Therapeutics
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. Orchard Therapeutics is traded on NASDAQ Exchange in the United States.

Orchard Therapeutics Stock Technical Analysis

Orchard Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Orchard Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Orchard Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Orchard Therapeutics Period Price Range

Low
December 2, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Orchard Therapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Orchard Therapeutics December 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Orchard Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orchard Therapeutics shares will generate the highest return on investment. By undertsting and applying Orchard Therapeutics stock market strength indicators, traders can identify Orchard Therapeutics PLC entry and exit signals to maximize returns

Orchard Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Orchard Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Orchard Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orchard to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Orchard Stock

If you are still planning to invest in Orchard Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orchard Therapeutics' history and understand the potential risks before investing.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity